FDA approves Genentech’s sNDA for influenza therapy in children

[cafead]

via The US Food and Drug Administration (FDA) has approved Genentech’s supplemental new drug application (sNDA) for xofluza (baloxavir marboxil) to treat influenza in children.

article source